PhD Candidate at Queensland University of Technology, Australia
Vijay Kumar Panthi is a dedicated pharmaceutical scientist specializing in drug formulation and development. With extensive experience in research and industry, he has contributed significantly to pharmaceutical advancements. His expertise spans nanoformulation, drug delivery, and analytical method validation. His work is driven by a passion for improving drug solubility, permeability, and efficacy, particularly in cancer and diabetes treatment.
profile
scopus
Education
Vijay Kumar Panthi earned his Master’s in Pharmacy (Pharmaceutics) from Mokpo National University, South Korea (2017–2019). Prior to this, he completed his Bachelor of Pharmacy at Tribhuvan University, Nepal (2010–2014). His academic journey also includes an intermediate diploma in Pharmacy from the Council for Technical Educational and Vocational Training (CTEVT), Nepal, and his high school education at Mukti Higher Secondary School.
Experience
Currently, Vijay serves as the Manager of Formulation, Research, and Development at Royal Sasa Nepal Pharmaceuticals. Previously, he held the same position at Corel Pharmaceuticals Pvt. Ltd. and has also worked as a formulation researcher at Mokpo National University. His professional background includes experience as a formulation and development pharmacist at Asian Pharmaceuticals Pvt. Ltd., where he honed his expertise in pharmaceutical production, research, and regulatory affairs.
Research Interests
Vijay’s research interests primarily focus on enhancing drug solubility and permeability for anticancer and antidiabetic therapies. His work includes developing nanoemulsions, hydrogels, and other advanced drug delivery systems. His contributions to pharmacokinetics and pharmaceutical technology are aimed at optimizing the efficacy of therapeutic agents.
Awards
-
Recognized for his contributions to pharmaceutical research and development in multiple institutions.
-
Awarded for his innovative formulation techniques and analytical methodologies in pharmaceutical sciences.
Publications
Panthi, V.K., et al. (2018). “Characterization and In Vivo Evaluation of an Oral Multiple Nanoemulsive System for Co-Delivery of Pemetrexed and Quercetin.” Pharmaceutics, MDPI, 10, 158.
Panthi, V.K., et al. (2017). “Preparation, Characterization, and Biological Activities of Topical Anti-Aging Ingredients in a Citrus junos Callus Extract.” Molecules, MDPI, 22, 2198.
Panthi, V.K., et al. (2022). “Formulation and Development of Adapalene Topical Nanohydrogel for Antiacne Activity.” Journal of Nanomaterials, Hindawi.
Panthi, V.K., et al. (2018). “Enhanced Oral Absorption of Pemetrexed by Ion-Pairing Complex Formation and Nanoemulsion Formulations.” International Journal of Nanomedicine.
Panthi, V.K., et al. (2021). “Formulation and Development of Serratiopeptidase Enteric Coated Tablets and Analytical Method Validation.” International Journal of Analytical Chemistry, Hindawi.
Panthi, V.K., et al. (2022). “A Validated RP-HPLC Method for Simultaneous Determination of Cefixime and Clavulanic Acid Powder in Pediatric Oral Suspension.” International Journal of Analytical Chemistry, Hindawi.
Panthi, V.K., et al. (2022). “Formulation and Development of Water-in-Oil Emulsion-Based Luliconazole Cream: Analytical Method Validation.” International Journal of Analytical Chemistry, Hindawi.
Conclusion
Considering his remarkable contributions to pharmaceutical sciences, innovative research in drug formulation, and dedication to advancing medical treatments, Vijay Kumar Panthi is a deserving candidate for the Best Researcher Award. His work has the potential to improve global healthcare outcomes, particularly in oncology, dermatology, and metabolic disorders. Recognizing his achievements would not only honor his efforts but also inspire future researchers in the field.